Intercept Pharmaceuticals
William Guilfoyle has extensive experience in the information technology sector, currently serving in IT at Intercept Pharmaceuticals since April 2023, a biopharmaceutical company focused on liver disease therapeutics. Prior to this role, William owned SENCOMM.net since September 1997 and held significant positions including Vice President and Global Head of End User Technology at First Data Corporation from January 2015 to November 2019, and Vice President in Information Technology at Barclays Capital from November 2005 to December 2014. Additional experience includes project leadership at L3 Communications and professional services at Globix Corporation, among other roles. William Guilfoyle completed education at Rochester Institute of Technology from June 1999 to December 2006.
This person is not in the org chart
This person is not in any teams
Intercept Pharmaceuticals
1 followers
Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.